Association between the timing of maternal vaccination and newborns' anti-pertussis toxin antibody levels.
Vaccine
; 37(36): 5474-5480, 2019 08 23.
Article
in En
| MEDLINE
| ID: mdl-31153689
ABSTRACT
BACKGROUND:
Pertussis remains an important global public health concern, despite the presence of extensive immunization programs. Incidence and severity of pertussis are typically higher in neonates and young infants. As a strategy to protect these young infants, maternal vaccination with Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) has been recommended in Brazil. The objective of this study was to evaluate the effects of Tdap vaccination during pregnancy on the anti-pertussis toxin (PT) IgG response in mothers and their infants at birth. MATERIAL ANDMETHODS:
Maternal and cord blood samples were collected from vaccinated (nâ¯=â¯243) and unvaccinated (nâ¯=â¯75) pregnant women, at the time of delivery, from July 2015 to August 2016 in São Paulo, Brazil. Anti-PT IgG antibodies were quantified by Enzyme-Linked Immunosorbent Assay (ELISA) and geometric mean concentrations (GMC) were calculated. Relationship between timing of vaccination and antibody concentrations were evaluated.RESULTS:
Maternal and cord blood GMCs among the vaccinated group were 5.4 and 5.6 fold higher [66.5 International Units (IU)/mL and 89.8â¯IU/mL] compared to the unvaccinated group (12.4â¯IU/mL and 16.1â¯IU/mL), respectively (pâ¯<â¯0.001). Higher anti-PT IgG GMCs were observed when vaccination occurred ≥60â¯days before delivery compared to <60â¯days, suggesting that vaccination early in the third trimester may be more effective than later in pregnancy.CONCLUSION:
Tdap maternal vaccination results in significantly higher anti-PT IgG in newborn infants and supports the current recommendation of the Brazilian Immunization Program.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Whooping Cough
/
Vaccination
/
Pertussis Toxin
Type of study:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Infant
/
Newborn
/
Pregnancy
Language:
En
Journal:
Vaccine
Year:
2019
Document type:
Article